Correlation Between Reviva Pharmaceuticals and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Effector Therapeutics, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Effector Therapeutics.
Diversification Opportunities for Reviva Pharmaceuticals and Effector Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and Effector is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Effector Therapeutics
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 0.71 times more return on investment than Effector Therapeutics. However, Reviva Pharmaceuticals Holdings is 1.41 times less risky than Effector Therapeutics. It trades about -0.01 of its potential returns per unit of risk. Effector Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 403.00 in Reviva Pharmaceuticals Holdings on August 28, 2024 and sell it today you would lose (288.00) from holding Reviva Pharmaceuticals Holdings or give up 71.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 79.8% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Effector Therapeutics
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Reviva Pharmaceuticals and Effector Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Effector Therapeutics
The main advantage of trading using opposite Reviva Pharmaceuticals and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |